Tuis1TWST • BIT
add
Twist Bioscience Corp
Vorige sluiting
€26,08
Jaarwisseling
€19,50 - €34,57
Markkapitalisasie
1,90 mjd USD
Gemiddelde volume
81,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 96,06 m | 17,91% |
Bedryfskoste | 81,42 m | 2,72% |
Netto inkomste | 20,39 m | 123,83% |
Netto winsgrens | 21,23 | 120,21% |
Wins per aandeel | -0,47 | 33,22% |
EBITDA | -24,06 m | 32,60% |
Effektiewe belastingkoers | 0,93% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 250,80 m | -13,34% |
Totale bates | 643,60 m | 0,86% |
Totale aanspreeklikheid | 165,41 m | 12,54% |
Totale ekwiteit | 478,20 m | — |
Uitstaande aandele | 60,36 m | — |
Prys om te bespreek | 3,28 | — |
Opbrengs op bates | -12,15% | — |
Opbrengs op kapitaal | -13,61% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 20,39 m | 123,83% |
Kontant van bedrywe | -1,40 m | 78,05% |
Kontant van beleggings | -9,40 m | -1 221,66% |
Kontant van finansiering | 1,83 m | -37,21% |
Netto kontantverandering | -9,04 m | -116,37% |
Beskikbare kontantvloei | -1,74 m | -128,89% |
Meer oor
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Gestig
2013
Webwerf
Werknemers
923